Cargando…

Editorial: Metabolism in Alzheimer's Disease

Detalles Bibliográficos
Autores principales:	Morris, Jill K., Wood, Levi B., Wilkins, Heather M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763976/ https://www.ncbi.nlm.nih.gov/pubmed/35058745 http://dx.doi.org/10.3389/fnins.2021.824145

Ejemplares similares

Editorial: Systemic implications of Alzheimer's disease
por: Cortes, Constanza J., et al.
Publicado: (2023)

Editorial: Alzheimer's Disease and the Fornix
por: Oishi, Kenichi, et al.
Publicado: (2016)

Editorial: The Alzheimer's Disease Challenge
por: Alexiou, Athanasios, et al.
Publicado: (2019)

Characterization of the Meal-Stimulated Incretin Response and Relationship With Structural Brain Outcomes in Aging and Alzheimer’s Disease
por: Morris, Jill K., et al.
Publicado: (2020)

Editorial: Nutrition and prevention of Alzheimer's disease
por: Perez-Cruz, Claudia, et al.
Publicado: (2015)

Editorial: Neurophysiology in Alzheimer's Disease and Dementia
por: Moretti, Davide V.
Publicado: (2016)

Editorial: Risk Factors for Alzheimer's Disease
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2020)

Application of Metabolomics in Alzheimer’s Disease
por: Wilkins, Jordan Maximillian, et al.
Publicado: (2018)

Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection
por: Wilkins, Heather M., et al.
Publicado: (2014)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Editorial: Biomarkers of Alzheimer’s Disease: The Present and the Future
por: Lehmann, Sylvain, et al.
Publicado: (2016)

Editorial: The Alzheimer's disease challenge, volume II
por: Kamal, Mohammad Amjad, et al.
Publicado: (2023)

Editorial: Insights in Alzheimer's disease and related dementias
por: Ibáñez, Agustín, et al.
Publicado: (2022)

Editorial: Immunological Mechanisms, Biomarkers and Immunotherapies of Alzheimer's Disease
por: Xin, Jia-yan, et al.
Publicado: (2021)

Editorial: Highlights in Alzheimer's and Parkinson's disease
por: Cantone, Mariagiovanna, et al.
Publicado: (2023)

Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II
por: Ma, Tao, et al.
Publicado: (2023)

Editorial: Mechanisms, markers and therapeutics of synaptic pathology in Alzheimer's disease
por: Metaxas, Athanasios, et al.
Publicado: (2022)

Editorial: ICT for Assessment and Rehabilitation in Alzheimer’s Disease and Related Disorders
por: Robert, Philippe, et al.
Publicado: (2016)

Editorial: Identification of Multiple Targets in the Fight Against Alzheimer's Disease
por: Giannoni, Patrizia, et al.
Publicado: (2020)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
por: Hillen, Heinz
Publicado: (2023)

Editorial: Insights in Alzheimer's disease and related dementias: 2022
por: Ibáñez, Agustín, et al.
Publicado: (2023)

Editorial: Deafness, aging and Alzheimer's disease: Neurobiological links and therapy options
por: Juiz, José M., et al.
Publicado: (2023)

Editorial: Progress of Translational Medicine in Alzheimer's Disease
por: Zhang, Can, et al.
Publicado: (2022)

Editorial: Improving memory deficits in Alzheimer's disease
por: Wang, Fushun, et al.
Publicado: (2022)

Editorial: The Involvement of NGF in the Alzheimer's Pathology
por: Cuello, A. Claudio
Publicado: (2019)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Editorial: Methods and applications in Alzheimer's disease and related dementias
por: Yogi, Alvaro, et al.
Publicado: (2022)

Aging, Metabolism, Synaptic Activity, and Aβ in Alzheimer's Disease
por: Gouras, Gunnar K.
Publicado: (2019)

Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
por: Yan, Xu, et al.
Publicado: (2020)

Iron Metabolism, Ferroptosis, and the Links With Alzheimer’s Disease
por: Yan, Nao, et al.
Publicado: (2020)

Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease
por: Zhang, Xin, et al.
Publicado: (2021)

Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases
por: Tikhonova, Maria A., et al.
Publicado: (2022)

Editorial: Clearance Pathways for Amyloid-β. Significance for Alzheimer's Disease and Its Therapy
por: Carare, Roxana O.
Publicado: (2017)

Editorial: Roles of Sleep Disruption and Circadian Rhythm Alterations on Neurodegeneration and Alzheimer's Disease
por: Duncan, Marilyn J., et al.
Publicado: (2021)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Redox signaling and metabolism in Alzheimer's disease
por: Holubiec, M. I., et al.
Publicado: (2022)

The Interaction Between Sleep and Metabolism in Alzheimer’s Disease: Cause or Consequence of Disease?
por: Carroll, Caitlin M., et al.
Publicado: (2019)

Editorial on Special Topic: Sirtuins in Metabolism, Aging, and Disease
por: Kazantsev, Aleksey G., et al.
Publicado: (2012)

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018)

Editorial: How does exercise modify the course of Alzheimer's disease?
por: Arciero, Paul J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4vkv3o5b5lifobm00m7ll1d3hm